CLOVER BIOPHARMACEUTICALS, LTD.

Insiders Clover Biopharmaceuticals, Ltd.

Equities

2197

KYG2280A1076

Delayed Hong Kong S.E. Other stock markets 04:47:17 16/05/2024 BST			5-day change	1st Jan Change
0.47 ^HKD	+5.62%		+14.29%	-22.58%

04-12	Clover Biopharmaceuticals, Ltd. announced that it has received $0.320713 million in funding	CI
04-08	Clover Biopharmaceuticals' RSV Vaccine Candidate Shows Promise in Early Trial	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Clover Biopharmaceuticals, Ltd. Announces Change of Joint Company Secretary	31/03/23	CI
Vaxart Appoints Phillip Lee as Chief Financial Officer	19/12/22	MT
Clover Biopharmaceuticals, Ltd. Announces Board Changes	28/10/22	CI
Clover Biopharmaceuticals, Ltd. Announces Executive Changes	01/07/22	CI
Clover Biopharmaceuticals, Ltd. Appoints Donna Ambrosino, M.D., and Ralf Clemens, M.D., Ph.D., to Board of Directors	20/06/22	CI
Clover Biopharmaceuticals, Ltd. Appoints Liongho Chua as President of Greater China	27/04/22	CI
Clover Biopharmaceuticals, Ltd. Announces Board Changes	22/04/22	CI
Clover Biopharmaceuticals, Ltd. Appoints Nicholas Jackson as President of Global Research and Development	01/02/22	CI
Clover Biopharmaceuticals, Ltd. Announces Executive Changes	22/12/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer